SmallCap
CompaniesStatistics

(주)알트메디칼

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)알트메디칼
Business Reg. No.2088130989
CEO유은희
Address서울특별시 성북구
Industry기초 의약 물질 제조업
Industry Code21100
Main Products치매 치료제 개발
EstablishedContact
Phone02-960-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
-1,076.3%
ROE
0.15%
Debt Ratio
111.95%

Certification Status


Venture Certified

Cert. History
벤처투자유형2023-06-14 ~ 2026-06-13202306140100032023-06-14

Financial Statements


3-Year Financial Data
Item202420232022
Revenue

0.2B

0.0B

0.0B

Operating Profit

-2.6B

-2.4B

-1.8B

Net Profit

0.0B

0.0B

0.0B

Total Assets

7.0B

6.4B

2.1B

Total Liabilities

3.7B

3.3B

0.1B

Total Equity

3.3B

3.0B

2.0B

Risk Indicators


1 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
240010K

0.0%

vs. 3-Year Avg.: 0
Operating Profit
-3B

25.3%

vs. 3-Year Avg.: -2B
Debt Ratio
111.9%

93.3%

vs. 3-Year Avg.: 57.9%
ROE
0.1%

40.5%

vs. 3-Year Avg.: 0.2%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
유은희대표이사대표

Employment Status


Regular EmployeesContact
CEO유은희

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울특별시 성북구",
  "ceo_name": "유은희",
  "certificate": [
    {
      "cert_number": "20230614010003",
      "changes": "",
      "disclosure_date": "2023-06-14",
      "first_cert_date": "2023-06-14",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2023-06-14 ~ 2026-06-13"
    }
  ],
  "company_name": "(주)알트메디칼",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 111120000,
      "cost_of_sales": 0,
      "current_assets": 32528000,
      "current_liabilities": 9938000,
      "gross_profit": 0,
      "net_income": 665000,
      "net_income_bs": 665000,
      "non_current_assets": 173056000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 176347000,
      "operating_profit": -175682000,
      "revenue": 0,
      "sga_expenses": 175682000,
      "total_assets": 205584000,
      "total_equity": 195646000,
      "total_liabilities": 9938000
    },
    "2023": {
      "capital_stock": 112240000,
      "cost_of_sales": 0,
      "current_assets": 422907000,
      "current_liabilities": 334383000,
      "gross_profit": 0,
      "net_income": 464000,
      "net_income_bs": 464000,
      "non_current_assets": 213375000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 3351000,
      "non_operating_income": 240370000,
      "operating_profit": -236555000,
      "revenue": 0,
      "sga_expenses": 236555000,
      "total_assets": 636282000,
      "total_equity": 301899000,
      "total_liabilities": 334383000
    },
    "2024": {
      "capital_stock": 112573000,
      "cost_of_sales": 0,
      "current_assets": 321848000,
      "current_liabilities": 310571000,
      "gross_profit": 24000000,
      "net_income": 488000,
      "net_income_bs": 476000,
      "non_current_assets": 382551000,
      "non_current_liabilities": 61483000,
      "non_operating_expenses": 13925000,
      "non_operating_income": 272731000,
      "operating_profit": -258318000,
      "revenue": 24000000,
      "sga_expenses": 282318000,
      "total_assets": 704399000,
      "total_equity": 332345000,
      "total_liabilities": 372054000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2022-04-11"
    }
  ],
  "main_products": "치매 치료제 개발",
  "phone": "02-960-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected